DIVISLAB's weekly return of 2.05% was a positive outcome, but it came with high volatility of 53.24%. The stock's Sharpe Ratio of 0.16 indicates a relatively low risk-adjusted return. Compared to its peers, DIVISLAB underperformed SUNPHARMA but outperformed DRREDDY and CIPLA. The stock's Max Drawdown of -3.27% suggests a moderate level of risk.

[Volatility: 53.24%]